Anti-inflammatory medications for obstructive sleep apnea in children
Cochrane Reviews, 02/01/2011
Kuhle SU – The review evaluate the effectiveness of anti–inflammatory drugs for the treatment of Obstructive sleep apnea (OSA) in children between one and 16 years of age. A comprehensive literature search identified three relevant studies.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.